Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Sep 6.
Published in final edited form as: Am J Med Sci. 2012 Aug;344(2):96–99. doi: 10.1097/MAJ.0b013e31823673fd

Does the relationship between natriuretic hormones and diastolic function differ by race?

Gaston K Kapuku 1,2, Harry C Davis 1, Patrick Thomas 3, James Januzzi 3, Gregory A Harshfield 1
PMCID: PMC3764598  NIHMSID: NIHMS339728  PMID: 22314104

Abstract

Background

Heart failure develops earlier and is more prevalent in Blacks (B) than Whites (W) due to their higher incidence of hypertension and diabetes and likely subsequent diastolic dysfunction. Natriuretic hormones (NP) prevent cardiac malfunction through pressure–natriuresis action. However, whether race affects the relationships of NP action with cardiac function is unknown.

Method

To assess this, fifty-five (21 whites and 27 males) normotensive adults underwent a 2 hour protocol of 40 minutes rest, video game stressor and recovery. Mitral inflow and myocardial velocities (tissue Doppler) were recorded every 20 minutes. Blood pressure (BP) and heart rate were obtained at 10 minute intervals. Blood samples for pro-atrial and pro-brain natriuretic peptides (pro-ANP and pro-BNP) were collected every 40 minutes.

Results

There were differences in the association between: (1) the changes from rest to stress for E/A ratio and double product (W r=−.42, B r=. 10; p=.034 for difference between correlations), (2) Stress Em and pro-ANP (W r=.59, B r=−.25, p=.025), (3) rest Em and BNP (W r=.83, B r=−.17, p=000), (4) rest Em/Am and pro-BNP ( W r = .70, B r=−.42, p=.003), (5) rest E/Em and pro-BNP ( W r=−.61, B r=.31, p=.015), (6) Stress E and pro-BNP (W r=.56, B r=−.18, p=.043).

Conclusion

The higher correlations between levels of NP and diastolic function indices both at rest and stress suggest that NP protective action is more pronounced in Whites than in Blacks.

Keywords: Natriuretic Hormones, Mental Stress, Diastolic Function, Race

Introduction

Epidemiologic studies have established that Blacks have higher prevalence of adverse patterns of cardiac structure, geometry and function13. Consequently, congestive heart failure (CHF) develops earlier and is more prevalent and faster progressing in Blacks than in Whites due to clustering of cardiovascular risk factors in Blacks including among other hypertension, obesity and diabetes 4,5. Blacks have two to three times greater mortality due to CHF than Whites6,7. This rate is still high when adjusting for co-variates (e.g., age, sex and cause of ventricular dysfunction). The underpinning mechanisms for ethnic differences in cardiac function of healthy individuals have not been fully elucidated.

Natriuretic peptides including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are major defense mechanisms against the effects of excess pressure and/or volume loads8,9. Natriuretic peptides cause natriuresis and vasodilatation through renal action (i.e., increased glomerular filtration rate) and through inhibition of the sympathetic nervous system, the renin-angiotensin-aldosterone system and endothelial regulation1015. We hypothesize that there are racial differences in cardioprotective factors such that Blacks might experience ineffective cardioprotective effects of natriuretic hormones.

The purpose of this study was to determine the influence of race on the relationship between the effects of natriuretic peptides and indices of heart function at rest and during mental stress stimulation.

Methods

Study Population

The subjects were 55 healthy normotensive adults aged 30 to 50 years-old. There were 22 Whites and 33 Blacks. Descriptive statistics of study participants are shown in Table 1. The protocol was approved by the Human Assurance Committee of the Medical College of Georgia. Written informed subject consent was obtained prior to testing.

Table 1.

Descriptive Statistics

Variable Blacks
n=33
Whites
n=22
p (2-tailed)
Sex 17M, 16F 10M, 12F 0.66
Age 40.9 ± 5.9 42.6 ± 4.4 0.21
Height (cm) 169.2 ± 10.1 172.1 ± 7.4 0.22
Weight (kg) 85.7 ± 21.1 79.0 ± 12.4 0.10
BMI 29.9 ± 6.6 26.3 ± 3.8 0.02
SBP 121.1 ± 13.8 116.1 ± 14.1 0.20
DBP 76 ± 8.5 73.9 ± 9.0 0.40
HR 70.6 ± 9.2 69.6 ± 8.2 0.71

Laboratory Evaluation

Participants were placed on a controlled, normal sodium (4000±200 mg/day) diet for 3 days prior to testing. On the fourth day, the participants were brought to the laboratory. During the 40 minutes pre-test period the subjects watched movies. The movies were limited to PG rated films which are nonviolent. Subjects’ interest was held so that they did not fall asleep. During the stress visit, this was followed by a 40 minutes stress period during which the subjects played a competitive video game task for a monetary reward (car driving, Sony Corp, Foster City CA). During the control visit, the protocol was the same except that during the “stress period” subjects watched movies. Finally, there was a 40 minutes post-test “recovery” period that was the same as the pre-test period.

Hemodynamic measurements were obtained during the two hours at 10 minute intervals using the Dinamap monitor (Dinamap Compact Monitor, Tampa FL) for blood pressure (BP) and heart rate (HR). Simultaneous with Dinamap measurements, a 40-second continuous sample of impedance waveforms was recorded using impedance cardiography (Cardiodynamics BioZ, CardiodynamiDiego, CA) for stroke volume (SV). The electrocardiography R-R intervals in this 40-second sample interval were assessed and converted into heart rate statements (i.e., beats per minute). Stroke volume was multiplied by heart rate to generate cardiac output (CO) values. Total peripheral resistance (TPR) was calculated using the equation TPR = mean arterial pressure (MAP)/CO. The ensemble averaging procedure improves signal sampling capabilities, as well as filtering respiratory and movement artifact, thereby optimizing the validity and reliability of impedance CO measurement16.

Doppler Evaluations of Global and Regional Diastolic Function

Mitral Inflow

For diastolic function pulsed Doppler Echocardiography was used to record the mitral inflow to derive indices of left ventricular filling. The sample volume was placed at the tips of mitral leaflets to record the highest velocity of diastolic inflow. The tracing of five consecutive cardiac cycles having the highest velocity in early filling were analyzed as previously described 17. The following parameters were examined: peak velocity of early filling (E); the acceleration (Acc.T) and deceleration (Dec.T) times, peak velocity of late filling (A) and the ratio of early to late filling peak velocities (E/A).

Tissue Doppler

TD was obtained by using an apical 4-chamber view for evaluating the mitral valve annulus. The sample volume was placed at the basal portion of the referred walls. The lowest possible wall filter setting and the minimum optimal gain were used as recommended by the manufacturer. Peak spectral longitudinal contraction (Sm), initial (Em), and final (Am) diastolic velocities for 5 consecutive beats were analyzed, E/Em and Em/Am ratio were calculated.

The reproducibility of both acquiring and measuring Sm, Em and Am were determined in recordings obtained from 10 subjects. The intra observer and inter observer differences in parameter estimates were less than 10%.

Natriuretic Peptide

Pro-ANP and Pro-BNP concentrations in plasma samples will be determined using commercially available kits purchased from Biomedica-Gruppe (American Research Products, Belmont, MA). 200 μL of standards, controls, and diluted samples (1:2 in assay buffer) and 100 μL of detection antibody will be added to a 96 well microtiter plate and incubated for 2.5 hours at 37 °C. Contents of wells will be discarded and washed. 100 μL of conjugate will be added to each well and samples will be incubated for one hour at room temperature. Contents of wells will be discarded again and washed. 100 μL of substrate will be added to all wells and samples will be incubated for 20 minutes at room temperature in the dark, at which point 50 μL of stop solution will be added to each well. Concentrations of pro-ANP and pro-BNP in samples will be determined by measuring absorbance at 450 nm and comparing to a calibration curve generated from the standards.

Statistical Analyses

Comparisons of mean values of the variables shown in Table 1 were made with t-tests. Covariance analyses were used to control for age, bmi, blood pressure, and systolic function when comparing Blacks and Whites on mean levels of pro-BNP and pro-ANP.

Pearson correlation coefficients were computed to assess the degree of linear association among the hemodynamic variables, Doppler measurements, and natriuretic peptide levels for the pre-test resting period, stress period, and the change from rest to stress. Spearman correlations were also computed in order to check for the effect of possible outliers on the Pearson correlations. SPSS version 19 (SPSS Inc, an IBM company) was used to perform most calculations. Comparisons of correlation coefficients were made using z-tests after r to z transformations.

Results

Black and White participants were similar with regard to age, sex distribution, height, blood pressure and heart rate. The average BMI was higher in Blacks than Whites (see Table 1).

Comparison of Cardiac Structure and Function

All individuals had normal left ventricular mass and geometry. Left ventricular systolic function was also normal for all individuals.

Impact of race on the association between diastolic function and natriuretic hormones

Whites and Blacks had normal diastolic function. A decrease in mean E/A ratio was observed during videogame stress. Em increased in Whites while it decreased in Blacks. E/Em decreased in Whites while it increased in Blacks (all ps <.01).

The association of change from rest to stress of E/A with double product (i.e., SBP X HR) was greater in Whites than Blacks (W r= −.42, B r= .10; p= .034 for difference between correlations) (see Figure 1). The association of Stress Em with ANP differed by race (W r=.59, B r=−.25, p=.025) (Figure 2).

Figure 1. Relationship Between Changes in E/A Ratio and Double Product by Race.

Figure 1

E/A: ratio of early (E) to late (A) filling velocities.

Figure 2. Relationship Between Em and pro-ANP by Race.

Figure 2

Em: myocardial relaxation

Pro-ANP: pro-Atrial Natriuretic Peptide

Whites compared to Blacks showed a greater association between pro-BNP and Em (W r=.83, B r=−.18, p=003) (see Figure 3) and Em/Am (W r = .72, B r=−.47, p=.002) (see Figure 4). The difference in the association between pro-BNP and E/E′ (W r=−.50, B r=.15, p=. 13) did not reach statistical difference.

Figure 3. Relationship Between Resting Myocardial Relaxation and pro-BNP by Race.

Figure 3

Em: myocardial relaxation

Pro-BNP: pro-Brain Natriuretic Peptide

Figure 4. Relationship Between Resting Mitral Annulus EM/AM and pro-BNP by Race.

Figure 4

Em/Am: ratio of early to late myocardial relaxation

Pro-BNP: pro-Brain Natriuretic Peptide

The Spearman correlations were quite similar to those obtained with the Pearson formula.

Discussion

Our major finding is that there is a race difference in the relationship between natriuretic hormones and heart function. This difference is independent of body size. In Whites, not in Blacks, higher blood levels of pro-BNP are associated with lower cardiac load, increased myocardial relaxation, and lower filling pressure. This suggests a race difference in the susceptibility to the cardioprotective effect of natriuretic hormones.

Left ventricular relaxation as reflected by Em is a preload independent marker of congestive heart failure18. To the best of our knowledge, this is the only study that has concomitantly examined the relationship between natriuretic hormones and myocardial relaxation in healthy humans and in a laboratory paradigm. The analyses were carried out in the entire sample and in each group separately to observe potential race specific effects. We found that greater Em was associated with increased pro-BNP only in Whites. The mechanisms of greater and beneficial associations in Whites are unclear from our study of healthy individuals. Also, the association between natriuretic hormones and diastolic function indices were evident in early diastole rather than late diastole suggesting that these hormones have greater influence on early phase relaxation than on compliance per se.

The modulating effect of race on blood levels of pro-BNP is controversial. Some19,20 but not all21 studies have shown race related differences in blood levels of pro-BNP. In the present study, blood levels of natriuretic hormones were not different between the two studied groups despite the greater BMI in Blacks and the well established negative association between BMI and pro-BNP22,23. No difference was found after taking into account covariates (e.g., blood pressure, age, cardiac structure and systolic function).

In a previous study using a similar protocol we have shown that race differences in pressure natriuresis is a mechanism of race related differences in heart structure and function24. The present study expands this concept to propose difference in sensitivity to natriuretic hormones as a mechanism that may explain race disparity in heart function. Our data suggest that Whites but not Blacks show the positive effect of natriuretic hormones on diastolic function.

Blood levels of natriuretic peptide did not differ by race. In both groups stress induced increase in blood pressure and heart rate whereas natriuretic blood levels were unaffected suggesting either that NP basal levels were enough to regulate stress induced changes in hemodynamics or that NP response to stress was delayed. Another possibility is that behavioral stress was not enough to affect natriuretic hormone release factors including increased body masse index, sex, age, ventricular wall tension, ventricular dysfunction, and subclinical myocardial injury and/or ischemia2527.

Kim et al.28 demonstrated that progression of left ventricular hypertrophy in end-stage renal disease patients is associated with rising filling pressure that parallels increasing blood levels of Nt-ProBNP. The findings in our study evoke a possible race difference in the beneficial effect of BNP and ANP. The associations between pro-ANP and pro-BNP and indices of diastolic function were moderately stronger in Whites than in Blacks. However, combining the standardized values of pro-ANP and pro-BNP to create a single index yielded an even stronger association, suggesting that biomarkers have stronger predictive value in White than in Blacks. The paradox of lack of association between diastolic function and natriuretic hormones in Blacks suggest that cardiac posttranslational process of natriuretic hormone precursors has ethnic variability and warrant myocardial characterization to further understand the influence of race on myocyte biology, receptor affinity and endopeptidase activity.

Perspective.

Existing studies have focused on natriuretic hormones as markers of cardiac dysfunction in patient populations but have not explored their homeostatic role in healthy individuals. Our study demonstrates that, within the normal range, levels of NP may be used to identify individuals at risk of developing cardiovascular disease. A longitudinal study will tie the observed race differences into concrete cardiovascular outcomes.

Acknowledgments

Supported by:

NIH: HL076696 and AHA: 0530046N

References

  • 1.Hebert LA, Agarwal G, Ladson-Wofford SE, Reif M, Hiremath L, Carlton SG, Nahman NS, Falkenhain ME, Agarwal A. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans. J Am Soc Nephrol. 1996;7:2130–4. doi: 10.1681/ASN.V7102130. [DOI] [PubMed] [Google Scholar]
  • 2.Kamath S, Markham D, Drazner MH. Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow? Heart Fail Rev. 2006;11:271–7. doi: 10.1007/s10741-006-0228-8. [DOI] [PubMed] [Google Scholar]
  • 3.Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio TA. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation. 1995;92:380–7. doi: 10.1161/01.cir.92.3.380. [DOI] [PubMed] [Google Scholar]
  • 4.Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A, Lewis CE, Williams OD, Hulley SB. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360:1179–90. doi: 10.1056/NEJMoa0807265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Volkova N, McClellan W, Soucie JM, Schoolwerth A. Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. Nephrol Dial Transplant. 2006;21:2202–9. doi: 10.1093/ndt/gfl078. [DOI] [PubMed] [Google Scholar]
  • 6.Jolly S, Vittinghoff E, Chattopadhyay A, Bibbins-Domingo K. Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites. Am J Med. 123:811–8. doi: 10.1016/j.amjmed.2010.04.020. [DOI] [PubMed] [Google Scholar]
  • 7.Williams RA. Cardiovascular disease in African American women: a health care disparities issue. J Natl Med Assoc. 2009;101:536–40. doi: 10.1016/s0027-9684(15)30938-x. [DOI] [PubMed] [Google Scholar]
  • 8.Waku S, Iida N, Ishihara T. Significance of brain natriuretic peptide measurement as a diagnostic indicator of cardiac function. Methods Inf Med. 2000;39:249–53. [PubMed] [Google Scholar]
  • 9.Otsuka T, Kawada T, Seino Y, Ibuki C, Katsumata M, Kodani E. Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease. Am J Cardiol. 106:1456–60. doi: 10.1016/j.amjcard.2010.06.075. [DOI] [PubMed] [Google Scholar]
  • 10.Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, Imura H. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991;84:1581–8. doi: 10.1161/01.cir.84.4.1581. [DOI] [PubMed] [Google Scholar]
  • 11.Sudoh T, Minamino N, Kangawa K, Matsuo H. Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem Biophys Res Commun. 1988;155:726–32. doi: 10.1016/s0006-291x(88)80555-2. [DOI] [PubMed] [Google Scholar]
  • 12.Lazzeri C, Franchi F, Porciani C, Fronzaroli C, Casini Raggi V, De Feo ML, Mannelli M, Cersosimo RM, La Villa G. Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. Am J Hypertens. 1995;8:799–807. doi: 10.1016/0895-7061(95)00147-h. [DOI] [PubMed] [Google Scholar]
  • 13.Trimarco B, Lembo G, De Luca N, Volpe M, Ricciardelli B, Condorelli G, Rosiello G, Condorelli M. Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor. Circulation. 1989;80:883–92. doi: 10.1161/01.cir.80.4.883. [DOI] [PubMed] [Google Scholar]
  • 14.van der Zander K, Houben AJ, Kroon AA, Wierema TK, Fuss-Lejeune MJ, Koster D, de Leeuw PW. Does brain natriuretic peptide have a direct renal effect in human hypertensives? Hypertension. 2003;41:119–23. doi: 10.1161/01.hyp.0000046496.73852.53. [DOI] [PubMed] [Google Scholar]
  • 15.Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, Ashida T, Sugiyama T, Hada Y, Kuwajima I, Nishinaga M, Akioka H, Nakajima O, Nagai R, Yazaki Y. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res. 2001;51:585–91. doi: 10.1016/s0008-6363(01)00320-0. [DOI] [PubMed] [Google Scholar]
  • 16.Sherwood A, Carter LS, Murphy CA. Cardiac output measurements by impedance cardiography: Comparison of two alternative methodologies against thermodilution values. Aviation, Space, and Environmental Medicine. 1991;62:116–122. [PubMed] [Google Scholar]
  • 17.Kapuku GK, Seto S, Mori H, Mori M, Utsunomia T, Suzuki S, Oku Y, Yano K, Hashiba K. Impaired left ventricular filling in borderline hypertensive patients without cardiac structural changes. Am Heart J. 1993;125:1710–6. doi: 10.1016/0002-8703(93)90763-y. [DOI] [PubMed] [Google Scholar]
  • 18.Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30:1527–33. doi: 10.1016/s0735-1097(97)00344-6. [DOI] [PubMed] [Google Scholar]
  • 19.Maisel AS, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg G, Westheim A, Knudsen CW, Perez A, Kazanegra R, Bhalla V, Herrmann HC, Aumont MC, McCullough PA. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J. 2004;147:1078–84. doi: 10.1016/j.ahj.2004.01.013. [DOI] [PubMed] [Google Scholar]
  • 20.Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK, Morrow DA, Drazner MH, McGuire DK, de Lemos JA. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study) Am J Cardiol. 2005;96:1284–9. doi: 10.1016/j.amjcard.2005.06.073. [DOI] [PubMed] [Google Scholar]
  • 21.Krauser DG, Chen AA, Tung R, Anwaruddin S, Baggish AL, Januzzi JL., Jr Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. J Card Fail. 2006;12:452–7. doi: 10.1016/j.cardfail.2006.04.005. [DOI] [PubMed] [Google Scholar]
  • 22.Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600. doi: 10.1161/01.CIR.0000112582.16683.EA. [DOI] [PubMed] [Google Scholar]
  • 23.Chen-Tournoux A, Khan AM, Baggish AL, Castro VM, Semigran MJ, McCabe EL, Moukarbel G, Reingold J, Durrani S, Lewis GD, Newton-Cheh C, Scherrer-Crosbie M, Kaplan LM, Wang TJ. Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels. Am J Cardiol. 106:1450–5. doi: 10.1016/j.amjcard.2010.06.076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Harshfield GA, Treiber FA, Davis H, Kapuku GK. Impaired stress-induced pressure natriuresis is related to left ventricle structure in blacks. Hypertension. 2002;39:844–7. doi: 10.1161/01.hyp.0000013735.85681.74. [DOI] [PubMed] [Google Scholar]
  • 25.Maeder MT, Mariani JA, Kaye DM. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension. 56:682–9. doi: 10.1161/HYPERTENSIONAHA.110.156547. [DOI] [PubMed] [Google Scholar]
  • 26.Hamano K, Abe M, Komi R, Kobayashi S. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria. Diabetes Metab Res Rev. 26:534–9. doi: 10.1002/dmrr.1113. [DOI] [PubMed] [Google Scholar]
  • 27.Wann BP, Audet MC, Anisman H. Impact of acute and chronic stressor experiences on heart atrial and brain natriuretic peptides in response to a subsequent stressor. Horm Behav. 58:907–16. doi: 10.1016/j.yhbeh.2010.09.001. [DOI] [PubMed] [Google Scholar]
  • 28.Kim YK, Shin SJ, Ihm SH, Park CS, Kim HY, Hong TY, Song HC, Yang CW, Kim YS, Choi EJ. Longitudinal changes of left ventricular filling pressure and N-terminal pro-brain natriuretic peptide on chronic hemodialysis. Clin Nephrol. 74:190–7. doi: 10.5414/cnp74190. [DOI] [PubMed] [Google Scholar]

RESOURCES